Laser Photonics Q2 shows sequential improvement but sharp YoY decline; defense progress still lacks funding

What happened

Laser Photonics reported Q2 2026 net sales of $1.806 million, down 30% year-over-year but nearly double the prior quarter's $0.9 million, and gross profit returned to positive territory at $152 thousand versus a gross loss in Q1. Gross margin remained depressed at 8.4% compared to 42.4% a year ago, and operating expenses rose 23% to $2.541 million, driving a net loss of $3.278 million, 85% worse than the year-ago quarter. Management highlighted sequential growth and the Laser Shield Anti-Drone System advancing through multiple U.S. Government evaluation gates, but no named, funded contract or prototype award was disclosed. The company continues to face substantial going-concern doubt and relies on external financing to fund operations. While the sequential improvement supports the base-case scenario of stabilizing commercial shipments, the absolute financial metrics remain weak, and the defense milestone remains qualitative.

Implication

The sequential rebound and positive gross margin align with the base-case scenario, but revenue of $1.806 million is still below the $2.0 million threshold that would suggest normalized absorption. Operating expenses continue to rise, and the net loss widened, indicating cash burn likely remains elevated. The anti-drone system advancing through evaluation gates is encouraging for optionality, but without a named, funded prototype or contract, it remains a story rather than a revenue driver. Given the continuing going-concern doubt and dependence on external financing, the stock's risk/reward is still skewed to dilution and downside. Investors should wait for evidence of sustained gross profit growth or a concrete defense award before adding exposure.

Thesis delta

The master report rated WAIT and saw two paths: commercial recovery and defense conversion. Q2 results confirm the commercial recovery is tentative: revenue nearly doubled sequentially and gross profit turned positive, meeting the base-case operating outcome, but absolute levels remain weak and losses widened. The defense narrative advanced qualitatively (multiple evaluation gates) but still lacks a named, funded step, so the bull case remains unproven. No change to the overall WAIT stance, but the window for a positive re-rating is narrowing if cash burn persists.